Shagun Singh Chadha
Stock Analyst at RBC Capital
(0.72)
# 3,778
Out of 4,339 analysts
634
Total ratings
43.5%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Shagun Singh Chadha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $100 | $57.64 | +73.49% | 55 | May 18, 2026 | |
| DXCM DexCom | Reiterated: Buy | $85 | $72.01 | +18.04% | 27 | May 15, 2026 | |
| TFX Teleflex | Upgraded: Buy | $135 → $155 | $131.89 | +17.52% | 50 | May 8, 2026 | |
| OM Outset Medical | Reiterated: Hold | $7 | $4.40 | +59.27% | 39 | May 8, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Hold | $175 | $147.75 | +18.44% | 11 | May 7, 2026 | |
| GMED Globus Medical | Maintained: Buy | $115 → $120 | $85.10 | +41.01% | 39 | May 7, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Buy | $30 | $14.54 | +106.33% | 19 | May 7, 2026 | |
| PODD Insulet | Reiterated: Buy | $325 → $280 | $153.80 | +82.05% | 16 | May 6, 2026 | |
| PEN Penumbra | Maintained: Hold | $374 | $328.20 | +13.95% | 37 | May 6, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $56 → $45 | $41.99 | +7.17% | 27 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $435 | $313.00 | +38.98% | 46 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $84.41 | +19.65% | 40 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $87.54 | +14.23% | 49 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 | $436.64 | +48.86% | 46 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $130 | $86.67 | +49.99% | 42 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $265 | $230.18 | +15.13% | 45 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 | $77.60 | +52.06% | 45 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $15.19 | n/a | 1 | Apr 29, 2021 |
Boston Scientific
May 18, 2026
Maintained: Buy
Price Target: $100
Current: $57.64
Upside: +73.49%
DexCom
May 15, 2026
Reiterated: Buy
Price Target: $85
Current: $72.01
Upside: +18.04%
Teleflex
May 8, 2026
Upgraded: Buy
Price Target: $135 → $155
Current: $131.89
Upside: +17.52%
Outset Medical
May 8, 2026
Reiterated: Hold
Price Target: $7
Current: $4.40
Upside: +59.27%
Becton, Dickinson and Company
May 7, 2026
Maintained: Hold
Price Target: $175
Current: $147.75
Upside: +18.44%
Globus Medical
May 7, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $85.10
Upside: +41.01%
Tandem Diabetes Care
May 7, 2026
Maintained: Buy
Price Target: $30
Current: $14.54
Upside: +106.33%
Insulet
May 6, 2026
Reiterated: Buy
Price Target: $325 → $280
Current: $153.80
Upside: +82.05%
Penumbra
May 6, 2026
Maintained: Hold
Price Target: $374
Current: $328.20
Upside: +13.95%
Inspire Medical Systems
May 4, 2026
Reiterated: Hold
Price Target: $56 → $45
Current: $41.99
Upside: +7.17%
May 1, 2026
Reiterated: Buy
Price Target: $435
Current: $313.00
Upside: +38.98%
Apr 28, 2026
Maintained: Buy
Price Target: $101
Current: $84.41
Upside: +19.65%
Apr 24, 2026
Maintained: Buy
Price Target: $100
Current: $87.54
Upside: +14.23%
Apr 21, 2026
Reiterated: Buy
Price Target: $650
Current: $436.64
Upside: +48.86%
Apr 16, 2026
Reiterated: Buy
Price Target: $135 → $130
Current: $86.67
Upside: +49.99%
Apr 14, 2026
Maintained: Buy
Price Target: $255 → $265
Current: $230.18
Upside: +15.13%
Apr 13, 2026
Maintained: Buy
Price Target: $118
Current: $77.60
Upside: +52.06%
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $15.19
Upside: n/a